insights_auto
Nega 207940 tushdi 3,01%?
Batafsil oʻrganishchevron_right
207940:KRX
Samsung Biologics Co Ltd
1 384 000,00 ₩
arrow_downward
-3,01%(-43 000,00) 1K
20-okt, 11:12:10 (GMT+9) · KRW
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto207940 tikeri uchun statistika yaratilmoqda...
Ochish
1 420 000 ₩
Yuqori
1 440 000 ₩
Past
1 383 000 ₩
Bozor kapitali
67,21 trln
Oʻrtacha hajm
53,12 ming
Hajmi
30,37 ming
P/E koeffitsiyenti
30,15
52 haftalik eng yuqori
1 973 600 ₩
52 haftalik eng past
1 110 460 ₩
Aksiya boʻyicha daromad
45 897 ₩
Muomaladagi aksiyalar
46,29 mln
Xodimlar soni
5 ming
Ochish
1 420 000 ₩
Yuqori
1 440 000 ₩
Past
1 383 000 ₩
Bozor kapitali
67,21 trln
Oʻrtacha hajm
53,12 ming
Hajmi
30,37 ming
P/E koeffitsiyenti
30,15
52 haftalik eng yuqori
1 973 600 ₩
52 haftalik eng past
1 110 460 ₩
Aksiya boʻyicha daromad
45 897 ₩
Muomaladagi aksiyalar
46,29 mln
Xodimlar soni
5 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Profil
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
Samsung Biologics Co Ltd haqida